Zevra Therapeutics (ZVRA) EBIT Growth (1y) (2015 - 2026)
Zevra Therapeutics (ZVRA) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
739.13 Mn |
538.51 Mn |
34.30 Mn |
1,072.51% |
| Date | Value |
|---|
| Mar 31, 2026 |
1,072.51% |
| Dec 31, 2025 |
160.42% |
| Sep 30, 2025 |
115.17% |
| Jun 30, 2025 |
-198.55% |
| Mar 31, 2025 |
73.83% |
| Dec 31, 2024 |
-1.71% |
| Sep 30, 2024 |
-77.73% |
| Jun 30, 2024 |
-280.60% |
| Mar 31, 2024 |
-59.66% |
| Dec 31, 2023 |
-62.75% |
| Sep 30, 2023 |
-12,391.06% |
| Jun 30, 2023 |
-12,925.00% |
| Mar 31, 2023 |
-590.21% |
| Dec 31, 2022 |
-227.69% |
| Sep 30, 2022 |
94.46% |
| Jun 30, 2022 |
-100.82% |
| Mar 31, 2022 |
-126.71% |
| Dec 31, 2021 |
11.57% |
| Sep 30, 2021 |
-83.18% |
| Jun 30, 2021 |
124.95% |
